Abstract
Premature ejaculation (PE) is the most common ejaculation disorder affecting all age groups. It is a clinical condition that causes psychological stress and loss of self-confidence in the patient and has a negative effect on quality of life. While the main treatment of primary PE is pharmacotherapy, treatment of the underlying secondary causes may be more important in acquired PE. Behavioral treatments should be used in the initial phase and accompany pharmacological treatments. Pharmacological agents that can be used in the treatment of PE are selective serotonin reuptake inhibitors (SSRI), topical anesthetics, tramadol, tricyclic antidepressants (TCA), phosphodiesterase-5 inhibitors (PDE5i), α-1 blockers and some combinations of these. Invasive interventions are experimental and not recommended by the guidelines. Patient and partner compatibility can be said to be the most important factor that brings success in treatment. Keywords: men, premature ejaculation, treatment
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
